Emergent Biosolutions
EBS
EBS
299 hedge funds and large institutions have $3.56B invested in Emergent Biosolutions in 2020 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 98 increasing their positions, 111 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 263 → 299 (+36)
1.53% less ownership
Funds ownership: 87.37% → 85.84% (-1.5%)
12% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 111
Holders
299
Holding in Top 10
7
Calls
$7.43M
Puts
$4.85M
Top Buyers
| 1 | +$50.2M | |
| 2 | +$28.3M | |
| 3 | +$23.3M | |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$23.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.7M |
Top Sellers
| 1 | -$98.1M | |
| 2 | -$23.6M | |
| 3 | -$20.8M | |
| 4 |
Renaissance Technologies
New York
|
-$18.9M |
| 5 |
Goldman Sachs
New York
|
-$16M |